blonanserin
SMILES | CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F |
InChIKey | XVGOZDAJGBALKS-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 3 |
Hydrogen bond donors | 0 |
Rotatable bonds | 3 |
Molecular weight (Da) | 367.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 9.09 | 9.09 | 9.09 | Guide to Pharmacology |
D2 | DRD2 | Human | Dopamine | A | pKi | 9.85 | 9.85 | 9.85 | Guide to Pharmacology |
H1 | HRH1 | Rat | Histamine | A | pKi | 5.52 | 5.52 | 5.52 | PDSP Ki database |
D1 | DRD1 | Rat | Dopamine | A | pKi | 5.54 | 5.54 | 5.54 | PDSP Ki database |
β2 | ADRB2 | Rat | Adrenoceptors | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
D2 | DRD2 | Rat | Dopamine | A | pKi | 7.83 | 7.83 | 7.83 | PDSP Ki database |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.04 | 8.04 | 8.04 | Drug Central |
α1A | ADA1A | Human | Adrenoceptors | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.01 | 8.01 | 8.01 | Drug Central |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 9.09 | 9.09 | 9.09 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 9.85 | 9.85 | 9.85 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |